SNCA and synucleinopathy: Providing further insights into the role of CMA in synucleinopathies, Malkus and Ischiropoulos recently showed that regional deficits in CMA might underlie α-synuclein aggregation and neurodegeneration in the human A53T α-synuclein transgenic mouse model [125].